10x Genomics (TXG) stock: insider trades, news & valuation
Heavy selling
Close · Oct 9, 2026
$80.65
+4.4% on the day
+588.7% over 12 months
52-week range $11.47 – $97.74
Share price and insider trades
TXG closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$16.9M
Insiders buying0
Insiders selling6
10x Genomics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 6 sold $16.9M of TXG stock on the open market.
Get emailed when insiders cluster-buy stocks like TXG
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
TXG insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $12.2M | 28 |
| Q2 2026 | — | 0 | $2.7M | 11 |
| Q1 2026 | — | 0 | $1.3M | 8 |
| Q4 2025 | — | 0 | $635K | 3 |
Valuation, profit and volume
P/E (trailing)n/aSector median —
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day2.0×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 10x Genomics, Inc. insiders reported open-market purchases totaling $0, while 6 insiders reported sales totaling $16.9M. 34 of 50 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 24SEC | Serge SaxonovCEO | Sell Plan | 9,9001,053,049 held (−1%) | $81.83 | $810K | -1.4% | — |
| Sep 24SEC | Serge SaxonovCEO | Sell Plan | 9,3001,062,949 held (−1%) | $80.90 | $752K | -0.3% | — |
| Sep 24SEC | Serge SaxonovCEO | Sell Plan | 2,8001,050,249 held (−0%) | $82.37 | $231K | -2.1% | — |
| Sep 24SEC | Shehnaaz SulimanDirector | Sell Plan | 2,27025,014 held (−8%) | $81.67 | $185K | -1.2% | — |
| Sep 24SEC | Serge SaxonovCEO | Sell Plan | 2,0001,072,249 held (−0%) | $79.62 | $159K | +1.3% | — |
| Sep 24SEC | Shehnaaz SulimanDirector | Sell Plan | 1,32527,284 held (−5%) | $80.82 | $107K | -0.2% | — |
| Sep 24SEC | Shehnaaz SulimanDirector | Sell Plan | 1,22223,792 held (−5%) | $82.28 | $101K | -2.0% | — |
| Sep 24SEC | Serge SaxonovCEO | Sell Plan | 1,0001,074,249 held (−0%) | $78.23 | $78K | +3.1% | — |
| Sep 24SEC | Shehnaaz SulimanDirector | Sell Plan | 61428,609 held (−2%) | $79.51 | $49K | +1.4% | — |
| Sep 24SEC | Shehnaaz SulimanDirector | Sell Plan | 29229,223 held (−1%) | $78.20 | $23K | +3.1% | — |
| Sep 11SEC | Adam TaichCFO | Sell Plan | 31,428330,098 held (−9%) | $64.31 | $2.0M | +25.4% | — |
| Sep 11SEC | Adam TaichCFO | Sell Plan | 13,754316,344 held (−4%) | $65.26 | $898K | +23.6% | — |
| Sep 11SEC | Adam TaichCFO | Sell Plan | 1,206361,526 held (−0%) | $63.68 | $77K | +26.6% | — |
| Sep 8SEC | John R StuelpnagelDirector | Sell | 7,012341,424 held (−2%) | $60.66 | $425K | +33.0% | — |
| Sep 8SEC | John R StuelpnagelDirector | Sell | 6,814334,610 held (−2%) | $62.11 | $423K | +29.9% | — |
| Sep 8SEC | John R StuelpnagelDirector | Sell | 6,174328,436 held (−2%) | $62.61 | $387K | +28.8% | — |
| Aug 28SEC | Serge SaxonovCEO | Sell Plan | 6,4941,075,841 held (−1%) | $63.98 | $415K | +26.1% | — |
| Aug 28SEC | Serge SaxonovCEO | Sell Plan | 3,5001,082,335 held (−0%) | $63.02 | $221K | +28.0% | — |
| Aug 28SEC | Serge SaxonovCEO | Sell Plan | 4921,075,349 held (−0%) | $64.75 | $32K | +24.6% | — |
| Aug 26SEC | Serge SaxonovCEO | Sell | 18,5451,085,835 held (−2%) | $63.02 | $1.2M | +28.0% | — |
| Aug 26SEC | Adam TaichCFO | Sell | 17,166362,732 held (−5%) | $63.02 | $1.1M | +28.0% | — |
| Aug 26SEC | Benjamin J. HindsonSee Remarks | Sell | 13,818488,182 held (−3%) | $63.02 | $871K | +28.0% | — |
| Aug 26SEC | Shehnaaz SulimanDirector | Sell Plan | 1,64629,515 held (−5%) | $63.97 | $105K | +26.1% | — |
| Aug 26SEC | Shehnaaz SulimanDirector | Sell Plan | 56131,161 held (−2%) | $62.73 | $35K | +28.6% | — |
| Aug 17SEC | Sarah A. TeichmannDirector | Sell Plan | 5,27830,331 held (−15%) | $57.29 | $302K | +40.8% | — |
| Aug 17SEC | Sarah A. TeichmannDirector | Sell Plan | 2,27328,058 held (−7%) | $57.15 | $130K | +41.1% | — |
| Aug 13SEC | John R StuelpnagelDirector | Sell | 17,000351,436 held (−5%) | $57.58 | $979K | +40.1% | — |
| Aug 13SEC | John R StuelpnagelDirector | Sell | 3,000348,436 held (−1%) | $58.73 | $176K | +37.3% | — |
| Jun 24SEC | Serge SaxonovCEO | Sell Plan | 9,8211,110,041 held (−1%) | $35.32 | $347K | +128.3% | — |
| Jun 24SEC | Serge SaxonovCEO | Sell Plan | 9,9911,119,862 held (−1%) | $34.28 | $342K | +135.3% | — |
| Jun 24SEC | Serge SaxonovCEO | Sell Plan | 8,5271,129,853 held (−1%) | $33.29 | $284K | +142.3% | — |
| Jun 24SEC | Serge SaxonovCEO | Sell Plan | 1,6611,108,380 held (−0%) | $36.16 | $60K | +123.0% | — |
| Jun 18SEC | Shehnaaz SulimanDirector | Sell Plan | 5,35932,086 held (−14%) | $32.59 | $175K | +147.5% | — |
| Jun 18SEC | Shehnaaz SulimanDirector | Sell Plan | 36431,722 held (−1%) | $33.27 | $12K | +142.4% | — |
| May 27SEC | Serge SaxonovCEO | Sell Plan | 18,1751,149,098 held (−2%) | $24.44 | $444K | +230.0% | — |
| May 27SEC | Adam TaichCFO | Sell | 15,098379,898 held (−4%) | $24.44 | $369K | +230.0% | — |
| May 27SEC | Benjamin J. HindsonSee Remarks | Sell | 11,595502,000 held (−2%) | $24.44 | $283K | +230.0% | — |
| May 27SEC | Serge SaxonovCEO | Sell Plan | 10,7181,138,380 held (−1%) | $24.71 | $265K | +226.4% | — |
| Apr 16SEC | Serge SaxonovCEO | Sell Plan | 5,0001,167,273 held (−0%) | $24.56 | $123K | +228.4% | — |
| Mar 25SEC | Serge SaxonovCEO | Sell Plan | 10,0001,177,273 held (−1%) | $19.13 | $191K | +321.6% | — |
| Mar 25SEC | Serge SaxonovCEO | Sell Plan | 5,0001,172,273 held (−0%) | $19.52 | $98K | +313.2% | — |
| Mar 4SEC | Serge SaxonovCEO | Sell Plan | 14,2921,205,527 held (−1%) | $22.67 | $324K | +255.8% | — |
| Mar 4SEC | Serge SaxonovCEO | Sell Plan | 1,8601,203,667 held (−0%) | $23.18 | $43K | +247.9% | — |
| Feb 27SEC | Sarah A. TeichmannDirector | Sell Plan | 7,57926,780 held (−22%) | $19.41 | $147K | +315.5% | — |
| Feb 25SEC | Serge SaxonovCEO | Sell | 9,6321,061,924 held (−1%) | $18.58 | $179K | +334.1% | — |
| Feb 25SEC | Adam TaichCFO | Sell | 8,968288,417 held (−3%) | $18.58 | $167K | +334.1% | — |
| Feb 25SEC | Benjamin J. HindsonSee Remarks | Sell | 7,826424,779 held (−2%) | $18.58 | $145K | +334.1% | — |
| Nov 25SEC | Serge SaxonovCEO | Sell | 13,2611,021,556 held (−1%) | $19.00 | $252K | +324.5% | — |
| Nov 25SEC | Adam TaichCFO | Sell | 11,888297,385 held (−4%) | $19.00 | $226K | +324.5% | — |
| Nov 25SEC | Benjamin J. HindsonSee Remarks | Sell | 8,283432,605 held (−2%) | $19.00 | $157K | +324.5% | — |
Insiders at 10x Genomics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Serge SaxonovCEO | — | $6.8M | Sep 24, 2026 | — |
| Adam TaichCFO | — | $4.8M | Sep 11, 2026 | — |
| John R StuelpnagelDirector | — | $2.4M | Sep 8, 2026 | — |
| Benjamin J. HindsonSee Remarks | — | $1.5M | Aug 26, 2026 | — |
| Shehnaaz SulimanDirector | — | $792K | Sep 24, 2026 | — |
| Sarah A. TeichmannDirector | — | $579K | Aug 17, 2026 | — |
TXG stock: common questions
Are 10x Genomics, Inc. insiders buying TXG stock?
In the past 12 months, 0 insiders reported open-market purchases of TXG worth $0.
Are 10x Genomics, Inc. insiders selling TXG stock?
6 insiders reported sales worth $16.9M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is TXG's 52-week range?
Over the past year TXG has traded between $11.47 and $97.74. It last closed at $80.65 on Oct 9, 2026.